Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly

Not Applicable

Terminated

• Conditions: Myocardial Ischemia
• Interventions: Other: diagnosis reassessment; Other: Diagnosis strategy and subsequent therapeutic reassessment

• Registration Number: NCT00224575
• Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Brief Summary

Despite the effectiveness of beta-blockers and antiplatelet agents for secondary prevention of coronary heart disease, this treatments are underused in the elderly because of diagnosis uncertainty and underuse of efficient treatment.

in a first time, diagnosis reassessment with invasive technique if necessary. in a second time, treatment reassessment.

Detailed Description

not desired

Study Timeline

• Study Start: 2004-11
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-23
• Primary Completion: 2005-11
• Study Completion: 2006-11
• Status Verified: 2016-03
• Last Update Submitted: 2016-03-07
• Last Update Posted: 2016-03-08

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 260

Inclusion Criteria

• patients 75 of age or older hospitalized in a geriatric service and suspect of coronary heart disease

Read More

Exclusion Criteria

• acute myocardial infarction

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	diagnosis reassessment	Diagnosis strategy and subsequent therapeutic reassessment All patients are in that arms. They all receive the diagnosis reassessment strategy.
1	Diagnosis strategy and subsequent therapeutic reassessment	Diagnosis strategy and subsequent therapeutic reassessment All patients are in that arms. They all receive the diagnosis reassessment strategy.

Primary Outcome Measures

Name	Time	Method
therapeutical impact of a reassessment strategy in the diagnosis of coronary heart disease in elderly	during hospitalization

Secondary Outcome Measures

Name	Time	Method
part link, in the treatment modification, with diagnosis reassessment and the part link with treatment optimization, death and rehospitalization in the subsequent 6 and 12 months	during hospitalization

Trial Locations

Locations (1)

Hopital Bichat; 🇫🇷 Paris, France